کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2502999 1557419 2011 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Cationic solid lipid nanoparticles (cSLN): Structure, stability and DNA binding capacity correlation studies
موضوعات مرتبط
علوم پزشکی و سلامت داروسازی، سم شناسی و علوم دارویی علوم دارویی
پیش نمایش صفحه اول مقاله
Cationic solid lipid nanoparticles (cSLN): Structure, stability and DNA binding capacity correlation studies
چکیده انگلیسی

Cationic solid lipid nanoparticles (cSLN) are promising lipid nanocarriers for intracellular gene delivery based on well-known and widely accepted materials. cSLN containing single-chained cationic lipid cetyltrimethylammonium bromide were produced by high pressure homogenization and characterized in terms of (a) particle size distribution by photon correlation spectroscopy (PCS) and laser diffractometry (LD), (b) thermal behaviour using differential scanning calorimetry (DSC) and (c) the presence of various polymorphic phases was confirmed by X-ray diffraction (WAXD). SLN composed of Imwitor 900P™ (IMW) showed different pDNA stability and binding capacity in comparison to those of Compritol 888 ATO™ (COM). IMW-SLN, having z-ave = 138–157 nm and d(0.5) = 0.15–0.158 μm could maintain this size for 14 days at room temperature. COM-SLN had z-ave = 334 nm and d(0.5) = 0.42 μm on the day of production and could maintain similar size during 90 days. IMW-SLN revealed improved pDNA binding capacity. We attempted to explain these differences by different interactions between the solid lipid and the tested cationic lipid.

Gel retardation assay. From left to right: (1) DNA ladder, (2)–(6) SLN-A:pDNA in ratios 50, 40, 30, 20, 10:1 (w/w), (7)–(11) SLN-B:pDNA in ratios 50, 40, 30, 20, 10:1 (w/w), (12)–(16) SLN-C:pDNA in ratios 50, 40, 30, 20, 10:1 (w/w), (17) DNA ladder, (18) free pDNA. Except SLN-C at 10:1 ratio, all complexes could prevent the pDNA from migration in electric field, proving its successful coupling with SLN.Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Journal of Pharmaceutics - Volume 420, Issue 2, 28 November 2011, Pages 341–349
نویسندگان
, , , , , , , , ,